Literature DB >> 10829263

Ureidopenicillins and beta-lactam/beta-lactamase inhibitor combinations.

L M Bush1, C C Johnson.   

Abstract

Although research and development of new penicillins have declined, penicillins continue to be essential antibiotics for the treatment and prophylaxis of infectious diseases. The most recent additions are the ureidopenicillins and beta-lactam/beta-lactamase inhibitor combinations. This article reviews the spectrum of activity, toxicity, pharmacokinetics, and clinical uses of the ureidopenicillins, and the beta-lactam/beta-lactamase inhibitor combination agents.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10829263     DOI： 10.1016/s0891-5520(05)70255-5

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN： 0891-5520            Impact factor:   5.982


  10 in total

1.  Dynamics of a nosocomial outbreak of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum beta-lactamase.

Authors:  F Luzzaro; E Mantengoli; M Perilli; G Lombardi; V Orlandi; A Orsatti; G Amicosante; G M Rossolini; A Toniolo
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

2.  Comparative Evaluation of the in-vitro Activity of Six β-lactam/β-lactamase Inhibitor Combinations against Gram Negative Bacilli.

Authors:  Smita Sood
Journal:  J Clin Diagn Res       Date:  2013-02-01

3.  Synthesis, spectral and extended spectrum beta-lactamase studies of transition metal tetraaza macrocyclic complexes.

Authors:  Dinesh Kumar; Nutan Sharma; Manjula Nair
Journal:  J Biol Inorg Chem       Date:  2017-01-18       Impact factor: 3.358

4.  Impacts of L1 Promoter Variation and L2 Clavulanate Susceptibility on Ticarcillin-Clavulanate Susceptibility of Stenotrophomonas maltophilia.

Authors:  Hsin-Hui Huang; Peng-Ying Chen; Rouh-Mei Hu; Yi-Tsung Lin; Li-Hua Li; Tsuey-Ching Yang
Journal:  Antimicrob Agents Chemother       Date:  2018-10-24       Impact factor: 5.191

5.  Supramolecular antibiotics: a strategy for conversion of broad-spectrum to narrow-spectrum antibiotics for Staphylococcus aureus.

Authors:  Thameez M Koyasseril-Yehiya; Alam García-Heredia; Francesca Anson; Poornima Rangadurai; M Sloan Siegrist; S Thayumanavan
Journal:  Nanoscale       Date:  2020-10-22       Impact factor: 7.790

Review 6.  Three decades of beta-lactamase inhibitors.

Authors:  Sarah M Drawz; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

7.  The effects of amoxicillin with or without clavulanic acid on the postoperative complaints after third molar surgery: a retrospective chart analysis.

Authors:  Alparslan Esen
Journal:  J Istanb Univ Fac Dent       Date:  2017-04-03

8.  Sensitivity of levofloxacin in combination with ampicillin-sulbactam and tigecycline against multidrug-resistant Acinetobacter baumannii.

Authors:  Nahid Madadi-Goli; Rezvan Moniri; Sareh Bagheri-Josheghani; Nilufar Dasteh-Goli
Journal:  Iran J Microbiol       Date:  2017-02

9.  Design, synthesis and microbiological evaluation of ampicillin-tetramic acid hybrid antibiotics.

Authors:  Philip T Cherian; Aditi Deshpande; Martin N Cheramie; David F Bruhn; Julian G Hurdle; Richard E Lee
Journal:  J Antibiot (Tokyo)       Date:  2016-05-18       Impact factor: 2.649

Review 10.  [Three keys to the appropriate choice of oral antibiotic treatment in the respiratory tract infections].

Authors:  R Menéndez; R Cantón; A García-Caballero; J Barberán
Journal:  Rev Esp Quimioter       Date:  2019-12-04       Impact factor: 1.553
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.